A comprehensive view of Diagnostic Tests / Monitoring Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
Eurofins outlines highlights from H2 2023, including organic core business growth, opening of new facilities
Published:
March 27, 2024
by Industry Intelligence Inc.
|
FDA approves Roche's cobas Malaria test for use on the cobas 6800/8800 Systems, making it the first molecular test for malaria screening in US; malaria affected about 292 million people in 2022, with Africa accounting for 94% of cases
Published:
March 26, 2024
by GlobeNewswire Europe
|
AHA says FDA's proposal to regulate laboratory developed tests could potentially limit patient access to effective care and stifle innovation in hospital and health system laboratory medicine
Published:
March 22, 2024
by The American Hospital Association (AHA)
|
Bayer and Thermo Fisher to develop next-generation sequencing-based companion diagnostic assays for precision cancer therapies; assays to use Thermo Fisher's Oncomine Dx Express Test and Genexus Dx System for fast genomic testing
Published:
March 21, 2024
by Associated Press
|
Thermo Fisher collaborates with Bayer to develop genomic testing assays for precision cancer treatment, introduces laboratory efficiency solutions like Diomni Software and QuantStudio 7 Pro Dx system, and focuses on environmental testing
Published:
March 21, 2024
by Industry Intelligence Inc.
|
Ask us about our Transformation & Innovation market view